News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
23 April 2024
Prof. Raymond Tjandrawinata, The Pioneer of Indonesia’s Indigenous Modern Medicine, Ranks Among The Top Three Pharmaceutical Scientists
Clinical and Molecular Pharmacologist Prof. Raymond Tjandrawinata of Dexa Group and Unika Atma Jaya, who also pioneers the development of Indonesia Indigenous Modern Medicine (OMAI), has achieved third place among the top pharmaceutical scientists in Indonesia. The AD Scientific Index provided this ranking based on a system that analyzes scientific…
8 April 2024
Implementation of ESG, Dexa Group Supports Research Facility at Rumah Perubahan
To encourage sustainable environment and implement Environmental, Social, and Governance (ESG) principles, Dexa Group supports research facilities at Rumah Perubahan by providing microscopes. The microscopes were presented by Dexa Group's Business Development and Scientific Affairs Director, Prof. Raymond Tjandrawinata, to the Founder of Rumah Perubahan, Prof. Rhenald Kasali on Friday,…
13 March 2024
Dexa Group Receives 3 Prestigious Awards from PRIA 2024
Successfully implementing public relations programs that create positive impact to society and company, Corporate Communications Dexa Group has won three awards at the Public Relations Indonesia Awards (PRIA) which took place on Thursday, March 7 2024 in Denpasar, Bali. Dexa Group's Corporate Communications won awards in the PR Program category…
12 March 2024
Dexa Group Collaborates with BKKBN and NTT Provincial Government to Hold Midwife Education to Reduce Stunting Rates
Dexa Group collaborates with the Badan Kependudukan dan Keluarga Berencana Nasional (BKKBN) of the Republic of Indonesia and the Provincial Government of Nusa Tenggara Timur (NTT) to conduct Midwife Education and Stunting Intervention in the First 1,000 Days of Life (HPK). The event, attended by hundreds of midwives in NTT,…
12 March 2024
Dexa Group Performs Community Service in Cataract Surgery and Tree Planting at RSUP dr. Ben Mboi Kupang
Based on the results of the Rapid Assessment of Avoidable Blindness (RAAB) survey by the Association of Indonesian Ophthalmologists (Perdami) and the Health Research and Development Agency (Balitbangkes) of the Indonesian Ministry of Health in 15 provinces in Indonesia in 2020, there were 1.6 million people suffering from blindness and…
20 February 2024
More Than 20 Years Trusted by Indonesian Families, STIMUNO Wins the 2024 Indonesia Healthcare Award
More Than 20 Years Trusted by Indonesian Families, STIMUNO Wins the 2024 Indonesia Healthcare Award Corporate News - STIMUNO, as the first phytopharmaceutical immunomodulator in Indonesia, clinically proven, halal certified, of high quality, and safe, has continued to be trusted by Indonesian families for over 20 years. In recognition of…
26 January 2024
Dexa Group Achieved Indonesia Public Relations Awards for the Sixth Time
Dexa Group has achieved the esteemed Indonesia Public Relations Awards (IPRA) 2024 in the category of Best Public Relations in the Pharmaceutical Industry from Warta Ekonomi. This recognition acknowledges Dexa Group's adept execution of a strategic role in public relations amid the challenges and uncertainties of business dynamics. Notably, this…